These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33232902)

  • 1. Generation of a human iPSC line from an epileptic encephalopathy patient with electrical status epilepticus during sleep carrying KCNA2 (p.P405L) mutation.
    Gong P; Jiao X; Zhang Y; Yang Z
    Stem Cell Res; 2020 Dec; 49():102080. PubMed ID: 33232902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of an induced pluripotent stem cell (iPSC) line (HIHDNEi003-A) from a patient with developmental and epileptic encephalopathy carrying a KCNA2 (p.Thr374Ala) mutation.
    Uysal B; Löffler H; Rosa F; Lerche H; Schwarz N
    Stem Cell Res; 2019 Oct; 40():101543. PubMed ID: 31465893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of a human induced pluripotent stem cell (iPSC) line (HIHDNEi002-A) from a patient with developmental and epileptic encephalopathy carrying a KCNA2 (p.Arg297Gln) mutation.
    Schwarz N; Uysal B; Rosa F; Löffler H; Mau-Holzmann UA; Liebau S; Lerche H
    Stem Cell Res; 2019 May; 37():101445. PubMed ID: 31075689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel clinical manifestations in patients with KCNA2 mutations.
    Sachdev M; Gaínza-Lein M; Tchapyjnikov D; Jiang YH; Loddenkemper T; Mikati MA
    Seizure; 2017 Oct; 51():74-76. PubMed ID: 28806589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of an induced pluripotent stem cell (iPSC) line from a patient with developmental and epileptic encephalopathy carrying a KCNA2 (p.Leu328Val) mutation.
    Schwarz N; Uysal B; Rosa F; Löffler H; Mau-Holzmann UA; Liebau S; Lerche H
    Stem Cell Res; 2018 Dec; 33():6-9. PubMed ID: 30292882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of three induced pluripotent stem cell (iPSC) lines from a patient with developmental epileptic encephalopathy due to the pathogenic KCNA2 variant c.869T>G; p.Leu290Arg (NUIGi052-A, NUIGi052-B, NUIGi052-C).
    Arbini A; Gilmore J; King MD; Gorman KM; Krawczyk J; McInerney V; O'Brien T; Shen S; Allen NM
    Stem Cell Res; 2020 Jul; 46():101853. PubMed ID: 32540721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genotype and phenotype of children with KCNA2 gene related developmental and epileptic encephalopathy].
    Gong P; Xue J; Jiao XR; Zhang YH; Yang ZX
    Zhonghua Er Ke Za Zhi; 2020 Jan; 58(1):35-40. PubMed ID: 31905474
    [No Abstract]   [Full Text] [Related]  

  • 8. De novo KCNA1 variants in the PVP motif cause infantile epileptic encephalopathy and cognitive impairment similar to recurrent KCNA2 variants.
    Rogers A; Golumbek P; Cellini E; Doccini V; Guerrini R; Wallgren-Pettersson C; Thuresson AC; Gurnett CA
    Am J Med Genet A; 2018 Aug; 176(8):1748-1752. PubMed ID: 30055040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel
    Imbrici P; Conte E; Blunck R; Stregapede F; Liantonio A; Tosi M; D'Adamo MC; De Luca A; Brankovic V; Zanni G
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical spectrum and genotype-phenotype associations of KCNA2-related encephalopathies.
    Masnada S; Hedrich UBS; Gardella E; Schubert J; Kaiwar C; Klee EW; Lanpher BC; Gavrilova RH; Synofzik M; Bast T; Gorman K; King MD; Allen NM; Conroy J; Ben Zeev B; Tzadok M; Korff C; Dubois F; Ramsey K; Narayanan V; Serratosa JM; Giraldez BG; Helbig I; Marsh E; O'Brien M; Bergqvist CA; Binelli A; Porter B; Zaeyen E; Horovitz DD; Wolff M; Marjanovic D; Caglayan HS; Arslan M; Pena SDJ; Sisodiya SM; Balestrini S; Syrbe S; Veggiotti P; Lemke JR; Møller RS; Lerche H; Rubboli G
    Brain; 2017 Sep; 140(9):2337-2354. PubMed ID: 29050392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dominant KCNA2 mutation causes episodic ataxia and pharmacoresponsive epilepsy.
    Corbett MA; Bellows ST; Li M; Carroll R; Micallef S; Carvill GL; Myers CT; Howell KB; Maljevic S; Lerche H; Gazina EV; Mefford HC; Bahlo M; Berkovic SF; Petrou S; Scheffer IE; Gecz J
    Neurology; 2016 Nov; 87(19):1975-1984. PubMed ID: 27733563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of a human iPSC line BCHNCi001-A from a patient with uridine-responsive epileptic encephalopathy carrying biallelic CAD mutations.
    Zhou L; Xu H; Wu Y; Fang F
    Stem Cell Res; 2022 Dec; 65():102947. PubMed ID: 36283272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy.
    Syrbe S; Hedrich UBS; Riesch E; Djémié T; Müller S; Møller RS; Maher B; Hernandez-Hernandez L; Synofzik M; Caglayan HS; Arslan M; Serratosa JM; Nothnagel M; May P; Krause R; Löffler H; Detert K; Dorn T; Vogt H; Krämer G; Schöls L; Mullis PE; Linnankivi T; Lehesjoki AE; Sterbova K; Craiu DC; Hoffman-Zacharska D; Korff CM; Weber YG; Steinlin M; Gallati S; Bertsche A; Bernhard MK; Merkenschlager A; Kiess W; ; Gonzalez M; Züchner S; Palotie A; Suls A; De Jonghe P; Helbig I; Biskup S; Wolff M; Maljevic S; Schüle R; Sisodiya SM; Weckhuysen S; Lerche H; Lemke JR
    Nat Genet; 2015 Apr; 47(4):393-399. PubMed ID: 25751627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe early-onset epileptic encephalopathy due to mutations in the KCNA2 gene: Expansion of the genotypic and phenotypic spectrum.
    Hundallah K; Alenizi A; AlHashem A; Tabarki B
    Eur J Paediatr Neurol; 2016 Jul; 20(4):657-60. PubMed ID: 27117551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of an iPSC line from a patient with early-onset epileptic encephalopathy carrying CARS2 (p.G476R) mutation.
    Xu M; Duan X; Ren X; Liu Z; Chen S; Fang F
    Stem Cell Res; 2022 Mar; 59():102633. PubMed ID: 34953328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tracking the motion of the K
    Pantazis A; Kaneko M; Angelini M; Steccanella F; Westerlund AM; Lindström SH; Nilsson M; Delemotte L; Saitta SC; Olcese R
    J Physiol; 2020 Nov; 598(22):5245-5269. PubMed ID: 32833227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of a human induced pluripotent stem cell line from an epilepsy patient carrying mutations in the PIK3R2 gene.
    Zhang B; Wang Y; Peng J; Hao Y; Guan Y
    Stem Cell Res; 2020 Apr; 44():101711. PubMed ID: 32155459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induced pluripotent stem cells (SHCDNi006-A cells) isolated from the peripheral blood mononuclear cells of a five-month-old Chinese girl with the heterozygous missense mutation (c.2800 G>A) in the KCNT1 gene.
    Luo X; Wang Y; Yuan F; Lin L; Wang A; Wang C; Guo M; Wang S; Wang C; Xu Q; Yin R; Cheng H; Zhang Y; Liu Z; Xu W; Yan J; Zeng F; Chen Y
    Stem Cell Res; 2022 Jul; 62():102798. PubMed ID: 35537242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression of alternating hemiplegia of childhood-related focal epilepsy to electrical status epilepticus in sleep with reversible encephalopathy.
    Neupert D; Abbassi P; Prange L; Flamini R; Mikati MA
    Epileptic Disord; 2022 Feb; 24(1):183-190. PubMed ID: 34789444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of a human iPSC line (ZJSHDPi001-A) from peripheral blood mononuclear cells of a patient with Developmental epileptic encephalopathy-47 carrying FGF12 gene mutation (c.334G > A).
    Gao L; Shi X; Su G; Guo Y; Lou Y; Wang Y; Miao P; Feng J
    Stem Cell Res; 2023 Sep; 71():103127. PubMed ID: 37331110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.